Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Given time investors will connect the dots...

<< Previous

Bullboard Posts

Next >>

Comment by jicoopon Mar 03, 2022 6:12pm

269 Views

Post# 34481082

RE:Given time investors will connect the dots...

and I'll this one step further ..

The three above statements taken alone do not seem much, but taken together it does mean that TLT cancer treatment will be able to treat cancer patients with a weakened immune system, or patients that do not respond to Chemotherapy, or patients that do not respond to Radiation Therapy, and finally treat patients that do not respond to BCG treatment.

How about we eliminate the need for thoses type of archaic and outdated treatments from ever being used again, and start cancer patients with TLT from the onset

Coop

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals